Skip to main content
Indian Journal of Otolaryngology and Head & Neck Surgery logoLink to Indian Journal of Otolaryngology and Head & Neck Surgery
. 2011 Feb 23;63(3):255–259. doi: 10.1007/s12070-011-0151-8

Ototoxicity: The Hidden Menace

Manisha Bisht 1,, S S Bist 2
PMCID: PMC3138949  PMID: 22754805

Abstract

Otolaryngology, although considered a surgical specialty, also covers many diseases that are not cured by surgery. These are treated medically and thus the otolaryngologist should have a good knowledge of drug treatments. It also entails ability to recognize, when an ENT symptom may be caused by one of the patient’s medications, particularly as this is easily remedied by changing the drug. Although most of us know the common drugs that can cause otological side effects, there are many others that we may not be aware of. Here we have tried to consolidate a list of some commonly used drugs having otological side effects.

Keywords: Ototoxicity, Ototoxic drugs, Hearing loss


Adverse drug events may not be recognized if physicians assume that pharmacologic therapy is always beneficial. It is just as important for clinicians to recognize the presence of an adverse drug event as it is to diagnose a serious disease [1].Otologic side effects of drugs are more common than people imagine. Each year, the side effects of ototoxic drugs disrupt millions of people’s lives and leave a trail of upheaval in their wake. The exact incidence of ototoxic side effects is not known, we apparently only see the tip of the iceberg. For extremely ototoxic drug such as cisplatin the chances of incurring hearing loss is almost 100% while it is estimated to be 63% with Aminoglycosides [2].Ototoxicity is defined as: ‘the tendency of certain therapeutic agents and other chemical substances to cause functional impairment and cellular degeneration of the tissues of the inner ear, and especially of the end-organs and neurons of the cochlear and vestibular divisions of the eight cranial nerve [3].’ Organ specific drug toxicity such as ototoxicity may result from a unique susceptibility of the injured tissue to the drug, accumulation of the drug within the organ, or a combination of both factors. Inner ear injury may result from reversible inhibition of normal physiological functions, such as endolymph formation, which if inhibited for prolonged periods of time results in degeneration of tissue dependent upon the particular physiological function. Direct toxic effects on the sensory end organs (i.e., hair cells) also play a role in drug induced toxicity. Some drugs also appear to have central effects, delaying brain stem auditory impulses or altering higher central processing so that patients wrongly complain of hearing loss which in turn is wrongly ascribed to an ototoxic action. For example, carbamazepine appears to dampen cortical responses to sound with an increased latency this effect may relate to the altered hearing that is sometimes noted in patients taking this drug. Some of the most important drugs are also potentially nephrotoxic, thus it is highly desirable to adjust the dose of an ototoxic drug on the basis of renal function test. Ototoxicity is not necessarily limited only to parenteral administration. Hearing loss has occurred with neomycin following irrigation of surgical wounds, superficial dressing of severe burns, aerosol inhalation, rectal and colonic irrigation, or even after oral administration [4]. Certain risk factors are associated with an increased incidence of drug induced ototoxicity. They include increased drug concentrations and/or prolonged exposure of the inner ear to the drug, dehydration, fever, noise exposure, preexisting sensoneural hearing loss, bacteremia, heredity, prior exposure to ototoxic agents, renal failure, presence of infected emboli, hypoxia and possibly old age [57]. Ototoxic synergism occurs if several ototoxic drugs are administered concurrently, potentiation of the ototoxicity is likely to occur, even when the dose of either drug is within the recommended limits [8]. Before prescribing any drug with ototoxic potential these group of high risk patients must be kept in mind. If possible, baseline audiometric and vestibular function test should be performed. Many ototoxic drugs begin destroying hearing at the highest frequencies first, and as the exposure continues, lower frequencies become involved. Since hearing is traditionally only tested up to 8 kHz, most initial cases of hearing loss from ototoxic drugs are never revealed by standard audiometric testing. High frequency audiometry can reveal the early effects of ototoxic drugs before tinnitus appears or hearing damage is visible on a conventional audiogram (250–8,000 Hz). Testing high frequencies between 125 and 20,000 Hz is time consuming and of course, adds additional expense to the evaluation. Fortunately, researchers have recently discovered a five frequency slope that is very sensitive to the ravage of ototoxic drugs. The beauty of this five frequency slope testing is that it is highly sensitive to initial ototoxic hearing loss [9]. Despite these general reservations about using the label ‘ototoxic’ rather freely, it is clear that several classes of drugs do damage the inner ear. There are at least 743 drugs that are known to be ototoxic [10]. Toxic effects on the structure of inner ear include ototoxicity resulting from adverse effects on the cochlea, producing hearing loss, and/or the vestibular apparatus, producing vertigo, ataxia, light headedness and other symptoms. Symptoms of ototoxicity vary considerably from drug to drug and person to person. They range from mild imbalance to total incapacitation and from tinnitus to total hearing loss. The primary warning symptoms of drug induced ototoxicity are tinnitus, hearing loss or disequilibrium. Although some of the side effects are irreversible others are reversible, and it is therefore worthwhile looking for alternatives. In addition, some drugs only cause their symptoms in high doses, and reducing the dose may remove the side effect. At present, there are no treatments that can reverse the damage. Our aim, however, must be to prevent or diminish adverse effects secondary to ototoxic drugs. This can be achieved by avoiding or discontinuing the ototoxic drug if a satisfactory alternative is available. It is not possible for a doctor to know all the possible drugs having a certain symptom as a side effect. The list of drugs given here can be used as a quick reference (Table 1, 2, 3) [11]. The list contains only commonly used drugs that can produce either otologic symptom. Physicians should be familiar with the common adverse effects of the drugs they use and when in doubt should consult the literature.

Table 1.

Drugs causing hearing loss as a side effect

Drug category Class of drug Subclass of drug Examples
Anti infective Antibiotics Aminoglycosides Neomycin, gentamicin, amikacin, netilmicin
Macrolides Erythromycin, azithromycin, clarithromycin
Quinolones Ofloxacin, ciprofloxacin, levofloxacin
Others Tetracyclines, vancomycin, teicoplanin, framycetin, colistin, imipenem with cilastin
Antivirals Ganciclovir, zalcitabine, ribavirin + interferon
Antifungals Amphotericin, flucytosine
Antimalarials Chloroquine, mefloquine, quinine
Antituberculous Capreomycin
Analgesics Non steroidal Aspirin, indomethacin, ibuprofen, diclofenac,
Anti-inflammatory Ketorolac, sulindac, naproxen,
Anticancer drugs Cytotoxics Platinum compounds Cisplatin, carboplatin, oxaloplatin
Vinca alkaloids Vindesine,vinblastine,vincristine
Others Bexarotene, taxane
Cardiac and vascular drugs Diuretics Loop diuretics Frusemide, bumentanide, torasemide
Carbonic anhydrase inhibitor Acetazolamide
Beta blockers Metoprolol, sotalol, practolol, bisopralol
ACE inhibitor Ramipril
Neurologic drugs Anticonvulsant Sodium valproate
Anti-Parkinson’s Entacapone
Others Immunosuppresant Tacrolimus
Antirheumatoid Hydroxychloroquine
Local anaesthetics Ropivacaine

Table 2.

Drugs causing tinnitus as a side effect

Drug category Class of drug Subclass of drug Examples
Anti infective Antibiotics Aminoglycosides Tobramycin, netilmicin, amikacin
Macrolides Clarithromycin, azithromycin
Quinolones Ciprofloxacin, ofloxacin, norfloxacin
Others Tetracyclines, vancomycin, teicioplanin, cotrimoxazole, cefpodoxime, linezolid
Antivirals Ganciclovir, zalcitabine,
Antifungals Amphotericin
Antimalarials Mefloquine, Quinine
Antituberculous Capreomycin
Analgesics diclofenac Non steroidal Aspirin, indomethacin, ibuprofen, diclofenac,
Anti-inflammatory Ketorolac, sulindac, naproxen, celecoxib
Anticancer drugs
Cardiac and vascular drugs
Cytotoxics Platinum compounds, Cisplatin, carboplatin
Vinca alkaloids Vindesine
Others Bexarotene, paclitaxel
Diuretics Loop diuretics Frusemide, torasemide
Potassium sparing diuretic Amiloride
Carbonic anhydrase inhibitor Acetazolamide
Beta blockers Metoprolol, timolol
Alpha blockers Prazocin
ACE inhibitor Ramipril, Enalapril, trandolapril
AT-II receptor Irbesartan
Antagonist
Anti arrhythmic Flecainide, quinidine, adenosine
Calcium channel blockers Diltiazem, nicardepine
Neurologic drugs Anticonvulsant Carbamazepine, fosphenytoin
Anti-depressant Tricyclics Imipramine, amitriptyline
SSRI Citalopram
Antimigraine 5HT-1 antagonist Almotriptan
Hypnotics Benzodiazepine (on withdrawal)
Others Immunosuppresant Tacrolimus
Antirheumatoid Hydroxychloroquine
Local anaesthetics Lignocaine
Hypoglycaemics Tolbutamide
Antihistamines Chlorpheniramine

Table 3.

Drugs causing vertigo or dizziness as a side effect

Drug category Class of drug Subclass of drug Examples
Anti infective Antibiotics Aminoglycosides Tobramycin, gentamicin, amikacin, netilmicin
Macrolides Erythromycin, azithromycin, clarithromycin
Quinolones Ofloxacin,ciprofloxacin, levofloxacin, norflox
Penicillins Piperacillin, amoxicillin
Cephalosporins Cefopodoxime, cefadroxil, ceftazidime, cefixime, cefalexin, cefaclor, cefazolin, ceftriaxone, cephradine
Others Tetracyclines, vancomycin, teicoplanin, metronidazole, tinidazole, clindamycin, cotrimaxazole, linezolid, pentamidine
Antivirals Ganciclovir,zalcitabine, acyclovir, ziduvudine, amantadine, ritonavir, lopinavir, indinavir
Antifungals Fluconazole, flucytosine, itraconazole, terbinafine, gresiofulvin
Antimalarials Hydroxychloroquine, mefloquine, lumefantine
Antituberculous Isoniazid,rifampicin, capreomycin, cycloserine
Antihelminthics Piperazine
Analgesics Non steroidal Aspirin, indomethacin, ibuprofen, diclofenac
Anti-inflammatory Ketorolac, sulindac, naproxen, celecoxib, mefenamic acid, aceclofenac, rofecoxib
Opioids Morphine, codeine, alfentamil, pethidine, tramadol, dextropropoxyphene
Anticancer drugs Cytotoxics Platinum compounds Cisplatin,
Vinca alkaloids Vinblastine
Antimetabolites Capecitabine, methotrexate, cytarabine
Others Etoposide, hydroxyurea, procarbazine, docetaxel
Cardiac and vascular drugs Diuretics Loop diuretics Frusemide, bumentanide, torasemide
Thiazides Indapamide, metolazone, bendrofluazide
Carbonic anhydrase inhibitor Acetazolamide, dorzolamide
Potassium sparing Amiloride, spironolactone
Beta blockers Metoprolol, timolol, propranolol, atenolol, pindolol, sotalol, labetolol, carvedilol
Alpha blockers Prazocin,terazosin, doxazocin, tamsulosin,
ACE inhibitor Ramipril, Enalapril, trandolapril, captopril, perindopril, lisinopril,
AT-II receptor antagonist Irbesartan,losartan,candesartan, valsartan
Anti arrhythmic Flecainide, quinidine, adenosine, digoxin amiodarone, bretylium, disopyramide
Calcium channel blockers Amlodipine, nifedipine, verapamil
Nitrates Isosorbide mononitrate, glyceryl trinitrate
Neurologic drugs Anticonvulsant Sodium valproate,carbamazepine phenytoin, gabapentin, tiagabine, lamotrigine, ethosuccimide
Anti-depressant Tricyclics Imipramine, amitriptyline, amoxapine,
SSRI Citalopram, fluoxetine, sertraline
MAO inhibitors Moclobemide
Antimigraine 5HT-1 antagonist Almotriptan, sumatriptan
Hypnotics Benzodiazepine Clonazepam, lorazepam, diazepam midazolam, alprazolam,
Other hypnotics Zopiclone, zolpidem
Anti-Parkinson’s Entacapone, selegiline, biperiden bromocriptine, pramipexole
Antipsychotics Thioridazine, olanzapine, clozapine chlorpromazine, haloperidol, serindole
Drugs for dementia Memantine, galantamine, donepezil,
Muscle relaxant Dantrolene, baclofen, tizanidine
Endocrine and metabolic Hypoglycemics Glipizide,glimepiride,pioglitazone, insulin
Corticosteroids Dexamethasone, fludrocortisone
Bisphosphonates Pamidronate, zoledronate
Gastro intestinal drugs Antiemetics Metoclopramide, ondansetron, nabilone trifluorperazine, tropisetron
Antiulcer H2 antagonist Ranitidine, cimetedine, famotidine
Proton pump Omeprazole,lasanoprazole, pantaprazole,
Inhibitors Promethazine, cetrizine, cyclizine
Lipid regulating Fenofibrate, simvastatin, colestipol
Others Immunosuppresant Tacrolimus, azathioprine, mycophenolate
Antirheumatoid Leflunomide, etanercept, azathioprine
Anti gout Allopurinol
Local anaesthetics Ropivacaine, lignocaine
Antihistamines Chlorpheniramine, fexofenadine promethazine, cetrizine, cyclizine
Antimuscarinics Atropine, hyoscine, dicyclomine
Antiasthamatics Salbutamol, montelukast, salmeterol

Conclusion

Drugs can be remarkably beneficial, prolonging life and improving its quality by reducing the symptoms. The beneficial effects of drugs are coupled with the inescapable risk of untoward effects. Otologic side effects of drugs are not uncommon and patients presenting to the otolaryngologist will often be taking drugs for the treatment of unrelated problem. Hence it is important to consider the medication of the patient presenting for the first time with an otologic symptom.

References

  • 1.Meville A. Set and serendipity in the detection of drug hazards. Soc Sci Med. 1984;19:391–396. doi: 10.1016/0277-9536(84)90196-5. [DOI] [PubMed] [Google Scholar]
  • 2.Fausti SA, et al. High frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. J Infect Dis. 1992;165(6):1026–1032. doi: 10.1093/infdis/165.6.1026. [DOI] [PubMed] [Google Scholar]
  • 3.Hawkins JE. Drug ototoxicity. In: Keidel WD, Neff WD, editors. Handbook of sensory physiology. Berlin: Springer-Verlag; 1976. pp. 707–748. [Google Scholar]
  • 4.Ballantyne J. Ototoxicity: a clinical review. Audiology. 1973;12:325. doi: 10.3109/00206097309071648. [DOI] [PubMed] [Google Scholar]
  • 5.Brown RD, Feldman AM. Pharmacology of hearing and ototoxicity. Ann Rev Pharmacol toxicol. 1978;18:233–252. doi: 10.1146/annurev.pa.18.040178.001313. [DOI] [PubMed] [Google Scholar]
  • 6.Bendush CL. Ototoxicity: clinical considerations and comparative information. In: Whelton A, Neu HC, editors. The aminoglycosides, microbiology, clinical use and toxicology. New York: Marcel Deckker; 1982. [Google Scholar]
  • 7.Bergstrom L, Thompson PL. Ototoxicity. In: Nourthern JL, editor. Hearing disorders. 2. Boston: Little Brown; 1984. pp. 253–266. [Google Scholar]
  • 8.Johnson AH, Hamilton WH. Kanamycin ototoxicity-possible potential by other drugs. South Med J. 1970;63:511–513. doi: 10.1097/00007611-197005000-00007. [DOI] [PubMed] [Google Scholar]
  • 9.Fausti SA, et al. High frequency audiometric monitoring for early detection of cisplatin ototoxicity. Arch Otolaryngol Head Neck Surg. 1993;119(6):661–666. doi: 10.1001/archotol.1993.01880180081015. [DOI] [PubMed] [Google Scholar]
  • 10.Cary R, Clarke S, Delic J. Effects of combined exposure to noise and toxic substances-critical review of literature. Ann Occup Hyg. 1997;41(4):455–465. doi: 10.1016/S0003-4878(97)00006-9. [DOI] [PubMed] [Google Scholar]
  • 11.Lee CA, Mistry D, Uppal S, Coatesworth AP. Otologic side effects of drugs. J Laryngol Otol. 2005;119:267–271. doi: 10.1258/0022215054020485. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Otolaryngology and Head & Neck Surgery are provided here courtesy of Springer

RESOURCES